Assessment of the emulsification of lipiodol in OK-432 suspended aqueous solution

Drug Delivery System

Volumn 11, Issue 2, 1996, Pages 111-118

  Rino, Yasushi ^a   Imada, Toshio ^a   Amano, Tomishige ^a   Matsumoto, Akihiko ^a   Motohashi, Hisahiko ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KANAGAWA CANCER CENTER   (Japan)

Author keywords

emulsion; Iopamiron 300; lipiodol; OK 432

Indexed keywords

EID: 85009539437     PISSN: 09135006     EISSN: 18812732     Source Type: Journal    
DOI: 10.2745/dds.11.111     Document Type: Article

References (19)

1. Rino, Y., Kobayashi, O., Sairenji, M. et al., : Investigations of emulsification of OK-432 solution one Lipiodol mixture. DDS 8 : 97-101, 1993.
2. Fujimaki, M., Kasaki, T. Tazawa, K. et al. : Oral administration of BRM (OK-432 medium chain triglyceride emulsion) and inhibition of hepatic metas tasis. DDS 4 : 276-280, 1989.
3. Nio, Y., Shiraishi, K., Tobe, K. : Effect of orally administered biololgical response modifiers (BRMs) on immunity of the gut. DOS 4 : 281-289, 1989.
4. Monden, T., Morimoto, H., Murotani, M. et al. : Intratumoral injection of OK-432 in conjunctiot with fibrinogen greatly enhances antitumor effect on colorectal carcinomas. J. Jpn. Surg. Soc. 92 : 31-36, 1991.
5. Monden, T., Morimoto, H., Murotani, M. et al. : Enhancement of antitumor effect of OK-432 by exogenous fibrinogens—a new approach local immunotherapy for carcinoma. Hiotherapy 5: 289-293, 1991.
6. Saeki, T., Kuninobu, H., Niimoto, M. et al. : A case of a recurence of gastric cancer with an abdomina wall tumor responding to intratumoral OK-432: administration. Jpn. J. Cancer Clin. 33 : 417-420 1987.
7. Ueno, K., Shibata, K., Saito, M. et al. : A case with recurrent gastric cancer showing regression upot intratumoral injection of OK-432. Biotherapy 3 : 1640-1643, 1989.
8. Yoshikawa, H., Muranishi, S. : Transfer to the lymphatic system. Modern Biopharmaceutics. (ed. Awazu, S., Koizumi, T.), Nankodo, Tokyo, 1991, p 90-98.
9. Nakamura, H., Hashimoto, T., Taguchi, T. et al. : Transcatheter oily chemoembolization in the treatment of unresectable hepatocellular carcinoma. J Clin. Exp. Med. 137 : 491-492, 1986.
10. Ohishi, H., Uchida, H., Yoshimura, H. et al., : He patocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology 154 : 25-29, 1985.
11. Sasaki, Y., Imaoka, S., Nakamori, S. et al. : Effect of intraarterial injection of Lipiodol-adriamycin suspension combined with arterial embolization on hepatocellular carcinoma. J. Jpn. Soc. Cancer Ther. 20 : 1357-1365, 1985.
12. Kajiya, Y., Kobayashi, H., Hidaka, H. et al. : MMC-oil suspension (MOC) as a new chemoemholic agent. Nippon Acta Radiologica 44 : 624-627, 1984.
13. Taniguchi, H., Yamaguchi, T., Takahashi, T. : Basic study of anti-cancer agents suspended in Lipiodol. Jpn. 3. Cancer Chemothera. 13 : 255-260, 1986.
14. Nakamura, H., Hashimoto, T., Taguchi, T. et al. : Stability of adriamycin-in-oil emulsion in hepatic artery chemoembolization, Jpn. J. Cancer Chemother. 13 : 3276-3279, 1986.
15. Ueno, M., Wakamatsu, N., Yoshimatsu, K. et al. : Control release of adriamycin from water-in-lipiodol emulsion and a comment on the measurement of drug release. Jpn. J. Cancer Chemother. 13 : 3291-3293, 1986.
16. Nakamura, H., Hashimoto, T., Taguchi, T. et al. : Transcatheter oily chemoembolization for hepatoccilular carcinoma using Adriamycin, Lipiodol and Gelfoam : pharmacokinetics Adriamycin. Jpn. J. Cancer Chemother. 13 : 623-625, 1986.
17. Maeda, H., Konno, T. : Tumor-targeted chemotherapy with an contrast medium and macromolecular anticancer agents theoretical considerations and clinical outcome. Jpn. J. Cancer Chemother. 12 : 773-782, 1985.
18. Rino, Y., Kobayashi, O., Sairenji, M. et al. : Translumber local injection of OK-432 on para-aortic lymph nodes for recurrence of gastric carcinoma. Jpn. J. Cancer Chemother. 20 : 1657-1660, 1993.
19. Rino, Y., Kobayashi, O., Sairenji, M. et al. : Possibility of chemotherapeutic lymph node dissection in lung metastasis of gastric cancer. DOS 8 : 45-47, 1993.